NeoRecormon bør administreres enten subkutant eller intravenøst for at øge hæmoglobinkoncentration til højst 12 g/ dl (7, 5 mmol/ l).
NeoRecormon should be administered either subcutaneously or intravenously in order to increase haemoglobin to not greater than 12 g/ dl (7.5 mmol/ l).